The Union Government of India has announced its plans to set up bone marrow transplant centres at three of its hospitals in Delhi.
The move comes in line with the government’s decision to offer affordable bone marrow transplants for patients, reported Times of India.
The centres are likely to be established at Safdarjung Hospital, Dr Ram Manohar Lohia (RML) Hospital and Lady Hardinge Medical College (LHMC) in Delhi.
An area has been identified and logistics are being procured at LHMC to start the bone marrow transplant facility, confirmed Lady Hardinge Medical College and the associated hospital director Dr Subhash Giri.
Currently, the facility is available only in one central government-run hospital, AIIMS Delhi, while transplant costs are higher in private hospitals.
The decision is expected to eliminate long waiting times for patients who earlier relied on AIIMS Delhi, which has the ability to perform 15 transplants per month.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIn addition, the maximum expenditure for a patient at the transplant centres will cost approximately Rs2 lakh ($2,442), in contrast to expenditures at private hospitals ranging from Rs12 lakh ($14,650) to Rs30 lakh ($36,627).
Safdarjung Hospital medical superintendent Dr BL Sherwal said: “We have the infrastructure and manpower, and the facility will soon start in the hospital.”
As per statistics revealed by the Indian Society for Blood and Marrow Transplantation, every year approximately 1,200 bone marrow transplants are performed in Delhi-NCR, including nearly 200 at AIIMS, while the total requirement is for 3,200 patients.